Becton, Dickinson Debt to Equity Ratio 2006-2018 | BDX

Current and historical debt to equity ratio values for Becton, Dickinson (BDX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.026B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $29.841B 88.22
McKesson (MCK) United States $27.107B 10.63
AmerisourceBergen (ABC) United States $18.976B 13.81
Laboratory Of America Holdings (LH) United States $18.944B 18.30
Cardinal Health (CAH) United States $15.376B 9.70
Cooper (COO) United States $12.118B 22.56
Henry Schein (HSIC) United States $11.358B 20.12
DENTSPLY SIRONA (XRAY) United States $10.062B 16.89
West Pharmaceutical Services (WST) United States $7.211B 40.17
Merit Medical Systems (MMSI) United States $2.816B 42.31
Patterson (PDCO) United States $2.110B 13.26
CONMED (CNMD) United States $2.063B 35.89
STAAR Surgical (STAA) United States $1.405B 482.14
Atrion (ATRI) United States $1.159B 33.09
Invacare (IVC) United States $0.695B 0.00
Endologix (ELGX) United States $0.449B 0.00
Antares Pharma (ATRS) United States $0.427B 0.00
Lifevantage (LFVN) United States $0.148B 30.74
Aceto (ACET) United States $0.100B 4.06
Milestone Scientific (MLSS) United States $0.030B 0.00
Pro-Dex (PDEX) United States $0.029B 12.89
Retractable Technologies (RVP) United States $0.027B 0.00
Biolase (BIOL) United States $0.026B 0.00